Factive
Product Images NDC 44001-321

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Factive (NDC 44001-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merus Labs International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Factive 5 Tablets (Factive 5 Count)

This appears to be a medication package for a drug called "gemifosac", marketed under the brand name "Factive". The package contains 5 tablets, each containing 920mg of gemifosacin. The drug is indicated for some sort of therapy, but the details are not provided. The packaging includes dosage instructions, and also prominently displays the product's NDC code and the manufacturer's name (Merus Labs).*

FDA Label Image

Factive 7 Tablets (Factive 7 Count)

Days of Therapy is a medication provided in a unit-of-use package, containing seven tablets of Gemifloxacin Mesylate. The tablets are taken once a day by the patients. The package has an NDC code of 44001-321-07 and is manufactured by Merus Labs. The medication should be stored at room temperature. The provided label should be attached to the pharmacy's packaging.*

FDA Label Image

Gemifloxacin Mesylate (Factive 1)

FDA Label Image

Creatinine Clearance Formula (Factive 2)

This is a formula for estimating creatinine clearance in men using their weight, age, and serum creatinine level.*

FDA Label Image

Merus-labs (Merus Labs)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.